EP2515652A4 - Zusammensetzungen und verfahren zur behandlung von vitiligo - Google Patents
Zusammensetzungen und verfahren zur behandlung von vitiligoInfo
- Publication number
- EP2515652A4 EP2515652A4 EP10840093.8A EP10840093A EP2515652A4 EP 2515652 A4 EP2515652 A4 EP 2515652A4 EP 10840093 A EP10840093 A EP 10840093A EP 2515652 A4 EP2515652 A4 EP 2515652A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- vitiligo
- compositions
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01006—Catalase (1.11.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01009—Glutathione peroxidase (1.11.1.9)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28868809P | 2009-12-21 | 2009-12-21 | |
US31567210P | 2010-03-19 | 2010-03-19 | |
PCT/US2010/061661 WO2011079154A1 (en) | 2009-12-21 | 2010-12-21 | Compositions and methods for treatment of vitiligo |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2515652A1 EP2515652A1 (de) | 2012-10-31 |
EP2515652A4 true EP2515652A4 (de) | 2014-11-26 |
Family
ID=44196131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10840093.8A Withdrawn EP2515652A4 (de) | 2009-12-21 | 2010-12-21 | Zusammensetzungen und verfahren zur behandlung von vitiligo |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2515652A4 (de) |
CA (1) | CA2822746A1 (de) |
WO (1) | WO2011079154A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5652795B2 (ja) * | 2011-01-31 | 2015-01-14 | 国立大学法人大阪大学 | 皮膚疾患を処置するための外用薬およびその製造方法 |
CN102552253A (zh) * | 2012-01-17 | 2012-07-11 | 唯美度科技(北京)有限公司 | 一种祛痘用皮肤外用剂 |
CN104324367A (zh) * | 2014-10-20 | 2015-02-04 | 广西壮族自治区花红药业股份有限公司 | 鱼鳞提取物在制备治疗和/或预防白癜风药物方面的新用途 |
AU2016325446B2 (en) * | 2015-09-24 | 2021-05-13 | Drexel University | Novel compositions and methods for treating or preventing dermal disorders |
US10493020B2 (en) | 2016-04-14 | 2019-12-03 | The Procter & Gamble Company | Method of improving the appearance of periorbital dyschromia |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999024036A1 (en) * | 1997-11-07 | 1999-05-20 | Aberdeen University | Skin penetration enhancing components |
US20030022911A1 (en) * | 2000-10-06 | 2003-01-30 | Smith Terry J. | Detection of antibody mediated inflammatory auto-immune disorders |
WO2009118191A2 (en) * | 2008-03-27 | 2009-10-01 | Clinuvel Pharmaceuticals Limited | Therapy for vitiligo |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362735A (en) * | 1994-02-23 | 1994-11-08 | Smithkline Beecham Corporation | Rapamycin derivatives |
WO2002062316A1 (de) * | 2001-02-08 | 2002-08-15 | Vectron Therapeutics Ag | Invasomen zur therapie von erkrankungen, ihre herstellung und verwendung |
US20070026042A1 (en) * | 2005-07-29 | 2007-02-01 | Narayanan Pallasssana V | System for treating aneurysmal disease |
-
2010
- 2010-12-21 EP EP10840093.8A patent/EP2515652A4/de not_active Withdrawn
- 2010-12-21 CA CA2822746A patent/CA2822746A1/en not_active Abandoned
- 2010-12-21 WO PCT/US2010/061661 patent/WO2011079154A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999024036A1 (en) * | 1997-11-07 | 1999-05-20 | Aberdeen University | Skin penetration enhancing components |
US20030022911A1 (en) * | 2000-10-06 | 2003-01-30 | Smith Terry J. | Detection of antibody mediated inflammatory auto-immune disorders |
WO2009118191A2 (en) * | 2008-03-27 | 2009-10-01 | Clinuvel Pharmaceuticals Limited | Therapy for vitiligo |
Non-Patent Citations (3)
Title |
---|
LISA B TRAVIS ET AL: "Successful Treatment of Vitiligo With 0.1% Tacrolimus Ointment The Cutting Edge: Challenges in Medical and Surgical Therapeutics REPORT OF CASES", ARCH DERMATOL, May 2003 (2003-05-01), pages 571 - 574, XP055146413, Retrieved from the Internet <URL:http://archderm.jamanetwork.com/data/Journals/DERM/11722/DCE20005.pdf> [retrieved on 20141014], DOI: 10.1001/archderm.139.5.571 * |
PASSERON ET AL: "Physiopathology and genetics of vitiligo", JOURNAL OF AUTOIMMUNITY, LONDON, GB, vol. 25, 2005, pages 63 - 68, XP005176440, ISSN: 0896-8411, DOI: 10.1016/J.JAUT.2005.10.001 * |
See also references of WO2011079154A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2515652A1 (de) | 2012-10-31 |
WO2011079154A1 (en) | 2011-06-30 |
CA2822746A1 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL258794B (en) | Methods and preparations for the diagnosis and treatment of cancer | |
EP2473054A4 (de) | Zusammensetzungen und verfahren zur behandlung von leukämie | |
EP2603202A4 (de) | Zusammensetzungen und verfahren zur behandlung von tauopathien | |
HK1226108A1 (zh) | 用於癌症治療的診斷方法和組合物 | |
ZA201105472B (en) | Methods and compositions for diagnosis and treatment of cancer | |
ZA201006988B (en) | Method and compositions for treatment of cancer | |
IL214455A0 (en) | Methods and compositions for treatment of neovascularization | |
IL215856A0 (en) | Compositions and methods for treatment of cardiovascular disease | |
EP2429584A4 (de) | Behandlungsverfahren und -zusammensetzungen | |
IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
GB0902040D0 (en) | Composition for treatment of skin | |
HK1167101A1 (en) | Compositions and methods for treatment of multiple sclerosis | |
EP2437738A4 (de) | Verfahren und zusammensetzungen zur krebsbehandlung | |
EP2515652A4 (de) | Zusammensetzungen und verfahren zur behandlung von vitiligo | |
EP2411031A4 (de) | Verfahren und zusammensetzungen zur behandlung von krebs | |
EP2473635A4 (de) | Zusammensetzungen und verfahren zur behandlung von neuropathischem schmerz | |
EP2411020A4 (de) | Zusammensetzungen und verfahren zur behandlung von blutungen | |
EP2462131A4 (de) | Zusammensetzungen und verfahren zur behandlung beta-amyloid-vermittelter erkrankungen | |
EP2440238A4 (de) | Behandlungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120716 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20141023 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/49 20060101ALI20141017BHEP Ipc: A61K 31/436 20060101ALI20141017BHEP Ipc: A61K 31/555 20060101ALI20141017BHEP Ipc: A61K 8/02 20060101AFI20141017BHEP Ipc: A61Q 19/08 20060101ALI20141017BHEP Ipc: A61Q 19/00 20060101ALI20141017BHEP Ipc: A61K 45/06 20060101ALI20141017BHEP Ipc: A61K 38/18 20060101ALI20141017BHEP Ipc: A61Q 19/02 20060101ALI20141017BHEP Ipc: A61K 9/06 20060101ALI20141017BHEP Ipc: A61K 9/00 20060101ALI20141017BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: 0901911 B. C. UNLIMITED LIABILITY COMPANY |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: 0901911 B. C. UNLIMITED LIABILITY COMPANY |
|
17Q | First examination report despatched |
Effective date: 20160523 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 45/06 20060101ALI20161024BHEP Ipc: A61K 38/44 20060101AFI20161024BHEP Ipc: A61K 31/555 20060101ALI20161024BHEP Ipc: A61K 8/49 20060101ALI20161024BHEP Ipc: A61K 31/407 20060101ALI20161024BHEP Ipc: A61K 38/18 20060101ALI20161024BHEP Ipc: A61Q 19/08 20060101ALI20161024BHEP Ipc: A61K 9/00 20060101ALI20161024BHEP Ipc: A61K 31/436 20060101ALI20161024BHEP Ipc: A61K 9/06 20060101ALI20161024BHEP |
|
INTG | Intention to grant announced |
Effective date: 20161117 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BACUS, SARAH |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20170328 |